A pharmaceutical composition comprising a synergic association of Vitamin D, Isoflavones and Policosanols and optionally one, two or three additional components selected among boswellic acids, curcumin and vitamin K for the treatment of cardiovascular diseases, in particular for reducing the process of vascular calcification and cholesterol levels and for increasing bone mineralization is described.
